CT
BIS icon

CMT Trading’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

CMT Trading’s Portfolio BIS Stock Details BIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-946
Closed -$210K – 29
2017
Q1 		$210K Buy
+946
New +$223K 0.29% 31
2016
Q3 		– Sell
-1,158
Closed -$385K – 39
2016
Q2 		$385K Buy
+1,158
New +$366K 0.65% 25

Other funds holding BIS

HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

CMT Trading's BIS Position: Q2 2017 in Review

CMT Trading sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q2 2017, closing a stake of 946 shares — an estimated $210K sold.

CMT Trading first reported a position in BIS in Q2 2016 and held it in 2 quarters. The position peaked at $385K in Q2 2016. 12 funds tracked by Wall St. Rank hold BIS as of Q2 2017.

  • CMT Trading reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q2 2017 after selling out during the quarter.
  • CMT Trading sold 946 ProShares UltraShort NASDAQ Biotechnology shares in Q2 2017, an estimated $210K.
  • CMT Trading first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q2 2016 and held it in 2 quarters.
  • CMT Trading's ProShares UltraShort NASDAQ Biotechnology position peaked at $385K in Q2 2016.
  • 12 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q2 2017.

Based on CMT Trading's 13F filing for Q2 2017, filed 14 Aug 2017.